Enlivex Therapeutics Correlations

ENLV Stock

USD 1.05 0.00 0.00%

The current 90-days correlation between Enlivex Therapeutics and Pluri Inc is 0.11 (i.e., Average diversification). The correlation of Enlivex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Enlivex Therapeutics Correlation With Market

Weak diversification

The correlation between Enlivex Therapeutics and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Enlivex Stock please use our How to Invest in Enlivex Therapeutics guide.

Moving together with Enlivex Stock

0.66

MKDW

MKDWELL Tech Ordinary

Pair Corr

Moving against Enlivex Stock

0.71	BB	BlackBerry	Pair Corr
0.54	VCSA	Vacasa Inc	Pair Corr
0.54	DT	Dynatrace Holdings LLC	Pair Corr
0.44	DQ	Daqo New Energy	Pair Corr
0.41	FUBO	Fubotv Inc	Pair Corr
0.77	FI	Fiserv,	Pair Corr
0.69	MX	MagnaChip Semiconductor	Pair Corr
0.67	JG	Aurora Mobile	Pair Corr
0.47	KD	Kyndryl Holdings	Pair Corr
0.31	DV	DoubleVerify Holdings	Pair Corr

Related Correlations Analysis

	PLUR	BLRX	PPBT	ARDS	HSTO	PMVP	APVO	PLX	CRVS	PHIO
PLUR		-0.06	-0.25	0.0	0.03	-0.19	-0.37	-0.12	-0.03	-0.33	PLUR
BLRX	-0.06		0.84	0.0	0.88	0.74	0.6	-0.82	0.58	0.28	BLRX
PPBT	-0.25	0.84		0.0	0.71	0.78	0.82	-0.56	0.64	0.42	PPBT
ARDS	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	ARDS
HSTO	0.03	0.88	0.71	0.0		0.68	0.52	-0.82	0.59	0.35	HSTO
PMVP	-0.19	0.74	0.78	0.0	0.68		0.76	-0.45	0.62	0.29	PMVP
APVO	-0.37	0.6	0.82	0.0	0.52	0.76		-0.34	0.58	0.51	APVO
PLX	-0.12	-0.82	-0.56	0.0	-0.82	-0.45	-0.34		-0.34	-0.23	PLX
CRVS	-0.03	0.58	0.64	0.0	0.59	0.62	0.58	-0.34		0.42	CRVS
PHIO	-0.33	0.28	0.42	0.0	0.35	0.29	0.51	-0.23	0.42		PHIO
	PLUR	BLRX	PPBT	ARDS	HSTO	PMVP	APVO	PLX	CRVS	PHIO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HSTO	+ 0.88	BLRX
PPBT	+ 0.84	BLRX
APVO	+ 0.82	PPBT
PMVP	+ 0.78	PPBT
APVO	+ 0.76	PMVP
PMVP	+ 0.74	BLRX

High negative correlations

PLX	- 0.82	HSTO
PLX	- 0.82	BLRX
PLX	- 0.56	PPBT
PLX	- 0.45	PMVP
APVO	- 0.37	PLUR
CRVS	- 0.34	PLX

Risk-Adjusted Indicators

There is a big difference between Enlivex Stock performing well and Enlivex Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enlivex Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PLUR	2.56	0.00	0.00	(0.07)	0.00	0.00	5.86	(4.98)	16.11
BLRX	5.25	(0.98)	0.00	(1.34)	0.00	0.00	9.73	(15.04)	60.21
PPBT	3.21	(0.37)	0.00	(0.48)	0.00	0.00	6.69	(7.10)	23.14
ARDS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HSTO	5.31	(1.64)	0.00	0.42	0.00	0.00	10.80	(10.71)	93.31
PMVP	1.83	(0.24)	0.00	(0.29)	0.00	0.00	4.41	(3.31)	16.42
APVO	3.94	(0.53)	0.00	(0.80)	0.00	0.00	8.25	(7.49)	30.46
PLX	2.57	0.59	0.20	0.69	2.49	(3.36)	6.37	(4.14)	16.96
CRVS	4.05	(0.56)	0.00	(0.95)	0.00	0.00	7.37	(6.50)	43.50
PHIO	11.03	2.00	0.17	0.42	9.59	(20.72)	9.40	(10.59)	336.29

Enlivex Therapeutics Corporate Management

Veronique AmorBaroukh	Senior Operations	Profile
Shachar CPA	Chief Officer	Profile
Oren Hershkovitz	Chief Officer	Profile
Pr MD	Founder Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC